Relation of Benefits to Risks of Treprostinil
Since treprostinil produces clinically meaningful effects without potentially life-threatening risks, both patients and physicians can weigh on an ongoing and individual basis the severity of infusion site pain against the magnitude of improvement in symptoms.
As a result, the benefits of treprostinil can be expected to outweigh the risks of treatment in each patient who continues to receive treatment with the drug.